A multi-omic method, which combined both proteomic and N-glycoproteomic analyses, was developed to analyze both the normal and cancerous bronchoalveolar lavage fluids (BALFs) of six lung adenocarcinoma patients for screening the new potential biomarkers of lung adenocarcinoma.